IgG glycan patterns—sugar structures attached to immune antibodies—function as modifiable biological aging markers that predict mortality risk and respond to interventions like therapeutic plasma exchange. Analysis of over 20,000 individuals across 42 studies establishes glycans as measurable indicators of immune aging that shift toward healthier profiles with targeted interventions.
Key Points
- IgG glycan patterns independently predict all-cause mortality across 20,000+ individuals
- Therapeutic plasma exchange reduced glycan age 0.4 years monthly in longitudinal studies
- Glycan signatures track chronic inflammation earlier than visible age-related symptoms
Longevity Analysis
Glycans represent a quantifiable bridge between immune function and biological aging. Rather than measuring years lived, this marker tracks the inflammatory state of the immune system—the underlying driver of age-related decline in cardiovascular health, physical resilience, and cognitive function. The capacity for glycan profiles to shift with plasma exchange demonstrates that markers previously considered fixed may respond to strategic intervention, establishing a measurable feedback mechanism for evaluating whether a given treatment actually modulates the aging process itself, not merely its symptoms.
Original published by Longevity.Technology, by Kyle Umipig.